Doctors investigate hidden risk when cancer patients mix common drugs
NCT ID NCT07384013
Summary
This study aims to understand if a pain medication called metamizole (Optalgin) changes the effectiveness of certain blood thinners in cancer patients. Researchers will measure blood thinner levels in 30 adult cancer patients who are taking both medications. The goal is to gather information to help doctors manage these drugs more safely together.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rambam Health Care Campus
RECRUITINGHaifa, 31096, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.